Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with irinotecan: results of an open-label, phase 1 study
Title:
Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with irinotecan: results of an open-label, phase 1 study
Author:
Tolcher, Anthony W. LoRusso, Patricia Arzt, Jennifer Busman, Todd A. Lian, Guinan Rudersdorf, Niki S. Vanderwal, Carol Ann Waring, Jeffrey F. Yang, Jianning Holen, Kyle D. Rosen, Lee S.